The Adult Congenital Heart Disease program at UC San Diego Health has received accreditation from the Adult Congenital Heart Association (ACHA) as a comprehensive care center, a first for San Diego.
Teams competing in the annual St. Baldrick’s event to raise money for childhood cancer research are preparing to go bald. UC Davis Health teams are still recruiting participants and donors ahead of the March 25 “shave off.”
UCSF researchers successfully leveraged an FDA-approved drug to halt growth of tumors driven by mutations in the RAS gene, which are famously difficult to treat and account for about one in four cancer deaths.
UC Davis Health is partnering with Pfizer on two new clinical trials. They are recruiting double-vaccinated healthy adults to assess the efficacy of different booster doses. They’re also testing heart muscle protein levels after a Pfizer booster shot.
The Pediatric Press newsletter communicates news and developments within the Children's Hospital. The goal is to connect and unite faculty and staff and provide information to employees at UC Davis Health and the general public.
